Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr109.50 DKK
Change Today -0.50 / -0.45%
Volume 58.7K
ZEAL On Other Exchanges
Symbol
Exchange
Copenhagen
Berlin
OTC US
OTC US
As of 11:07 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ZEALAND PHARMA A/S (ZEAL)

Zealand Pharma A/S to Report Nine Months, 2015 on Nov 05, 2015
CapIQ 11/05/2015 5:00 AM ET
Zealand Pharma A/S to Report First Half, 2015 on Aug 28, 2015
CapIQ 11/05/2015 5:00 AM ET
Zealand Pharma A/S to Report Q1, 2015 on May 22, 2015
CapIQ 11/05/2015 5:00 AM ET

2013 revenues at Zealand Pharma A/S totaled kr6.6M DKK, while annual losses equaled kr8.10 per share.

Quarterly Earnings & Estimates - ZEALAND PHARMA A/S (ZEAL)

Actuals vs. Estimates for ZEALAND PHARMA A/S ZEAL

Zealand Pharma A/S's Quarterly Earnings

Zealand Pharma A/S reported 2nd quarter 2014 losses of kr2.10 per share on 08/23/2014.

Annual Earnings & Estimates - ZEALAND PHARMA A/S (ZEAL)

Actuals vs. Estimates for ZEALAND PHARMA A/S ZEAL

Zealand Pharma A/S's Annual Earnings

Zealand Pharma A/S reported annual 2013 losses of kr8.10 per share on 03/22/2014.

Quarterly Revenues - ZEALAND PHARMA A/S (ZEAL)

Actuals vs. Estimates for ZEALAND PHARMA A/S ZEAL

Zealand Pharma A/S's Quarterly Revenues

Zealand Pharma A/S had 2nd quarter 2014 revenues of kr4.3M DKK. This missed the kr7.8M DKK estimate of the one analyst following the company. This was 297.6% above the prior year's 2nd quarter results.

Annual Revenues - ZEALAND PHARMA A/S (ZEAL)

Actuals vs. Estimates for ZEALAND PHARMA A/S ZEAL

Zealand Pharma A/S's Annual Revenues

Zealand Pharma A/S had revenues for the full year 2013 of kr6.6M DKK. This was -97.1% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZEAL:DC kr109.50 DKK -0.50

ZEAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ZEAL.
View Industry Companies
 

Industry Analysis

ZEAL

Industry Average

Valuation ZEAL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 34.2x
Price/Book 12.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZEALAND PHARMA A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.